Search

Your search keyword '"Equipe EPICAD (LNC - U1231)"' showing total 58 results

Search Constraints

Start Over You searched for: Author "Equipe EPICAD (LNC - U1231)" Remove constraint Author: "Equipe EPICAD (LNC - U1231)"
58 results on '"Equipe EPICAD (LNC - U1231)"'

Search Results

1. A new cure model that corrects for increased risk of non-cancer death: analysis of reliability and robustness, and application to real-life data

2. The economic, medical and psychosocial consequences of whole genome sequencing for the genetic diagnosis of patients with intellectual disability: The DEFIDIAG study protocol

3. Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials

4. Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study

5. The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer

6. Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab

7. What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort

8. Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer

9. Douleur et Souffrance : représentations croisées des Oncologues et des Patients, une étude qualitative

10. Modeling excess hazard with time‐to‐cure as a parameter

11. Intra-arterial idarubicin_lipiodol without embolization can provide prolonged complete response in hepatocellular carcinoma: A case report

12. Cost-effectiveness of diagnostic tests for threatened preterm labor in singleton pregnancy in France

13. Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study

14. A retrospective analysis of the impact of treatments and blood counts on survival and the risk of vascular events during the course of polycythaemia vera

15. Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers

16. Épidémiologie des tumeurs neuroendocrines intestinales

17. Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 - REGOLD

18. Cancérologie, la douleur en question : Représentations sociales, Regards croisés des Médecins oncologues et des Patients

19. Trends in incidence of small bowel cancer according to histology: a population-based study

20. The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis

21. Net survival in recurrence-free colon cancer patients

22. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study

23. Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study

24. Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial

25. FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial

26. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients

27. Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial

28. A new approach to estimate time-to-cure from cancer registries data

29. Prevalence and distribution of HPV genotypes and cervical-associated lesions in sexually active young French women following HPV vaccine

30. Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: a French randomised double-blind phase III trial (PRODIGE 50-ASPIK)

31. Efficacy, safety and cost of pomalidomide in relapsed and refractory multiple myeloma

32. Intra-arterial Idarubicin_lipiodol without embolization in hepatocellular carcinoma: the LIDA-B phase I trial

33. Analyse économique des essais cliniques internationaux en cancérologie

34. Identification of resources and skills developed by partners of patients with advanced colon cancer: a qualitative study

35. Outcomes following polypectomy for malignant colorectal polyps are similar to those following surgery in the general population

36. A systematic review of economic evaluation in pancreatic ductal adenocarcinoma

37. Survival of solid cancer patients in France, 1989-2013: a population-based study

38. Focus on an unusual rise in pancreatic cancer incidence in France

39. PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers

40. Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours

41. Waldmann's disease: a rare cause of protein losing enteropathy in an adult patient

42. Analyse économique des essais cliniques internationaux en cancérologie

43. Inégalités géographiques et socio-économiques de détection des adénomes colorectaux avant et pendant le dépistage organisé du cancer colorectal : une étude de population

44. Adjuvant chemotherapy versus perioperative chemotherapy (CTx) for resectable gastric signet ring cell (SRC) gastric cancer: A multicenter, randomized phase II study (PRODIGE 19)

45. Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma

46. Incidence of solitary pulmonary nodules in Northeastern France: a population-based study in five regions

47. Trends in net survival from stomach cancer in six European Latin countries: results from the SUDCAN population-based study

48. Trends in net survival from liver cancer in six European Latin countries

49. Trends in net survival from esophageal cancer in six European Latin countries

50. Trends in net survival from pancreatic cancer in six European Latin countries

Catalog

Books, media, physical & digital resources